51. Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker.
- Author
-
Chen AX, Gartrell RD, Zhao J, Upadhyayula PS, Zhao W, Yuan J, Minns HE, Dovas A, Bruce JN, Lasorella A, Iavarone A, Canoll P, Sims PA, and Rabadan R
- Subjects
- Cell Communication genetics, Fluorescent Antibody Technique, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Glioblastoma metabolism, Glioblastoma mortality, High-Throughput Nucleotide Sequencing, Humans, Immunohistochemistry, Isocitrate Dehydrogenase genetics, Mutation, Prognosis, Tumor Microenvironment genetics, Tumor Microenvironment immunology, Tumor-Associated Macrophages pathology, Biomarkers, Tumor, Glioblastoma diagnosis, Glioblastoma etiology, Receptors, Immunologic genetics, Single-Cell Analysis methods, Tumor-Associated Macrophages metabolism
- Abstract
Background: Macrophages are the most common infiltrating immune cells in gliomas and play a wide variety of pro-tumor and anti-tumor roles. However, the different subpopulations of macrophages and their effects on the tumor microenvironment remain poorly understood., Methods: We combined new and previously published single-cell RNA-seq data from 98,015 single cells from a total of 66 gliomas to profile 19,331 individual macrophages., Results: Unsupervised clustering revealed a pro-tumor subpopulation of bone marrow-derived macrophages characterized by the scavenger receptor MARCO, which is almost exclusively found in IDH1-wild-type glioblastomas. Previous studies have implicated MARCO as an unfavorable marker in melanoma and non-small cell lung cancer; here, we find that bulk MARCO expression is associated with worse prognosis and mesenchymal subtype. Furthermore, MARCO expression is significantly altered over the course of treatment with anti-PD1 checkpoint inhibitors in a response-dependent manner, which we validate with immunofluorescence imaging., Conclusions: These findings illustrate a novel macrophage subpopulation that drives tumor progression in glioblastomas and suggest potential therapeutic targets to prevent their recruitment.
- Published
- 2021
- Full Text
- View/download PDF